miRNAs as Potential Treatment Targets and Treatment Options in Cancer.
作者： Nina Petrovic , Sercan Ergun
DOI: 10.1007/S40291-017-0314-8
关键词: Oncology 、 Chemotherapy 、 Medicine 、 Pharmacotherapy 、 Cancer 、 Molecular medicine 、 Internal medicine 、 Radiation therapy 、 microRNA 、 Cancer cell 、 Cancer Model
摘要: Standard cancer therapies for solid malignancies, such as chemotherapy and radiotherapy, are not target specific against cancer cells and are often not fully efficacious. Chemotherapy …
springer.com
sci-hub.se 参考文章(73)
Azadeh Azizian, Frank Kramer, Peter Jo, Hendrik A. Wolff, Tim Beißbarth, Robert Skarupke, Markus Bernhardt, Marian Grade, B. Michael Ghadimi, Jochen Gaedcke, Preoperative Prediction of Lymph Node Status by Circulating Mir-18b and Mir-20a During Chemoradiotherapy in Patients with Rectal Cancer World Journal of Surgery. ,vol. 39, pp. 2329- 2335 ,(2015) , 10.1007/S00268-015-3083-8
Alessandra Tessitore, Germana Cicciarelli, Valentina Mastroiaco, Filippo Del Vecchio, Daria Capece, Daniela Verzella, Mariafausta Fischietti, Davide Vecchiotti, Francesca Zazzeroni, Edoardo Alesse, Therapeutic Use of MicroRNAs in Cancer Anti-cancer Agents in Medicinal Chemistry. ,vol. 16, pp. 7- 19 ,(2015) , 10.2174/1871520615666150824153358
E Korpela, D Vesprini, S K Liu, MicroRNA in radiotherapy: miRage or miRador? British Journal of Cancer. ,vol. 112, pp. 777- 782 ,(2015) , 10.1038/BJC.2015.6
Pedro M. Borralho, Betsy T. Kren, Rui E. Castro, Isabel B. Moreira da Silva, Clifford J. Steer, Cecília M. P. Rodrigues, MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS Journal. ,vol. 276, pp. 6689- 6700 ,(2009) , 10.1111/J.1742-4658.2009.07383.X
Hao Bo, Zhaojian Gong, Wenling Zhang, Xiayu Li, Yong Zeng, Qianjin Liao, Pan Chen, Lei Shi, Yu Lian, Yizhou Jing, Ke Tang, Zheng Li, Yanhong Zhou, Ming Zhou, Bo Xiang, Xiaoling Li, Jianbo Yang, Wei Xiong, Guiyuan Li, Zhaoyang Zeng, Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. ,vol. 6, pp. 20404- 20418 ,(2015) , 10.18632/ONCOTARGET.4057
Guangya Xiang, Taotao Zhou, Li Zhang, Fangqi Peng, Yifei Huang, Peng Ye, Miao Lu, Guang Yang, Yongkang Gai, Tan Yang, Xiang Ma, Wendian Zhang, Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes International Journal of Nanomedicine. ,vol. 10, pp. 4825- 4836 ,(2015) , 10.2147/IJN.S79598
Michele Dal Bo, Riccardo Bomben, Luis Hernández, Valter Gattei, The MYC/ miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential Oncotarget. ,vol. 6, pp. 19381- 19392 ,(2015) , 10.18632/ONCOTARGET.4574
Min-Sun Song, John J. Rossi, The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30 Frontiers in Genetics. ,vol. 4, pp. 301- 301 ,(2014) , 10.3389/FGENE.2013.00301
Phong Trang, Jason F Wiggins, Christopher L Daige, Chris Cho, Michael Omotola, David Brown, Joanne B Weidhaas, Andreas G Bader, Frank J Slack, Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice Molecular Therapy. ,vol. 19, pp. 1116- 1122 ,(2011) , 10.1038/MT.2011.48
Amit Arora, Eric M. Scholar, Role of Tyrosine Kinase Inhibitors in Cancer Therapy Journal of Pharmacology and Experimental Therapeutics. ,vol. 315, pp. 971- 979 ,(2005) , 10.1124/JPET.105.084145